Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia

Fig. 3

Analysis of the prognostic value of TNFAIP2 expression on overall survival (OS) in different types of cancers by Timer 2.0 database. a BLAC, (b) SARC, (c) SKCM, (d) STAD, (e) LAML, (f) KIRC, (g) LGG, (h) THYM, (i) UVM. (LAML, acute myeloid leukemia; BLCA, bladder urothelial carcinoma; KIRP, kidney renal papillary cell carcinoma; LGG, brain lower grade glioma; SARC, sarcoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma; THYM, thymoma; UVM, uveal melanoma)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us